Article
Contribution of Type II Topoisomerase Mutations to Fluoroquinolone Resistance in Enterococcus faecium from Japanese Clinical Setting.
Microbial drug resistance (Larchmont, N.Y.) - 1 Jan 2000
Urushibara Noriko, Suzaki Keisuke, Kawaguchiya Mitsuyo, Aung Meiji Soe, Shinagawa Masaaki, Takahashi Satoshi, Kobayashi Nobumichi
Abstract excerpt
High-level fluoroquinolone resistance is conferred by the mutation of conserved serine and acidic amino acids in the quinolone resistance-determining region (QRDR) of the A subunits of the type II topoisomerases, DNA gyrase (GyrA) and topoisomerase IV (ParC). In Japan, fluoroquinolone-resistant Enterococcus faecium continues to emerge in clinical settings. We analyzed 131 Japanese E. faecium clinical isolates for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
